Earlier this month, the FDA required that a black box warning—the most serious category— be placed on the "super hepatitis C drugs," such as Sovaldi and Harvoni.
News and analysis on drug development, clinical evidence, regulatory approvals, pharmacology, and the science behind treatments — from small molecules to biologics.
